Robert E. Levitz
Impact in
- Microbiology top 10%
- Bacterial Infections and Vaccines
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Pneumocystis jirovecii pneumonia detection and treatment 3
- Pneumonia and Respiratory Infections 3
- Infective Endocarditis Diagnosis and Management 2
-
- Antibiotics Pharmacokinetics and Efficacy 4
- Co-authors
- Brian Cooper (5 shared papers)Richard Quintiliani (3 shared papers)C H Nightingale (2 shared papers)Richard C. Tilton (2 shared papers)Michael N. Dudley (1 shared paper)Lee Brettman (2 shared papers)Christopher Grace (1 shared paper)Allan J. Morrison (1 shared paper)
- Journals
- Infection Control and Hospital Epidemiology (4 papers)Clinical Infectious Diseases (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)American Journal of Clinical Pathology (1 paper)Journal of Clinical Microbiology (1 paper)
- Partner nations
- United States
In The Last Decade
Robert E. Levitz
15 papers receiving 405 citations
Peers
Comparison fields: 5 of 74
- Microbiology 64
- Molecular Medicine 42
- Hepatology 61
- Epidemiology 225
- Infectious Diseases 106
Countries citing papers authored by Robert E. Levitz
This map shows the geographic impact of Robert E. Levitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Levitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Levitz more than expected).
Fields of papers citing papers by Robert E. Levitz
This network shows the impact of papers produced by Robert E. Levitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Levitz. The network helps show where Robert E. Levitz may publish in the future.
Co-authors
The 16 scholars most cited alongside Robert E. Levitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1984 | 94 | |
| 2 | 1998 | 75 | |
| 3 | 1984 | 62 | |
| 4 | 1992 | 42 | |
| 5 | 1988 | 31 | |
| 6 | 1992 | 27 | |
| 7 | 1987 | 25 | |
| 8 | 1995 | 23 | |
| 9 | 1995 | 17 | |
| 10 | 1988 | 11 | |
| 11 | 1992 | 9 | |
| 12 | Infection with the human immunodeficiency virus (HIV) as a risk factor for bacteremic illness due to Streptococcus pneumoniae. | 1988 | 8 |
| 13 | 1987 | 6 | |
| 14 | 1988 | 6 | |
| 15 | 1987 | 3 |
About Robert E. Levitz
Robert E. Levitz is a scholar working on Epidemiology, Pharmacology, Infectious Diseases, Molecular Medicine and Surgery, having authored 15 papers that have together received 439 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Pneumonia and Respiratory Infections (3 papers), Antibiotic Resistance in Bacteria (3 papers), Streptococcal Infections and Treatments (2 papers), Infective Endocarditis Diagnosis and Management (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers) and Hepatitis C virus research (2 papers). The work is most often cited by research in Microbiology (64 citations), Molecular Medicine (42 citations), Hepatology (61 citations), Epidemiology (225 citations) and Infectious Diseases (106 citations). Robert E. Levitz has collaborated with scholars based in United States. Frequent co-authors include Brian Cooper, Richard Quintiliani, C H Nightingale, Richard C. Tilton, Michael N. Dudley, Lee Brettman, Christopher Grace, Allan J. Morrison, C. W. Ingram and Helen M. Crowe. Their work appears in journals such as Infection Control and Hospital Epidemiology, Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy, American Journal of Clinical Pathology and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.